Andropause: Myths and Management

Résumé fourni par la source

Over the past two decades, prescription rates for testosterone have risen sharply, due to direct‑to‑consumer advertising and the spread of online misinformation. As a result, the topic of andropause, or aging-associated testosterone deficiency, is increasingly encountered by Canadian primary care physicians. Despite its growing visibility, up to 25% of healthcare practitioners report challenges in accurately diagnosing and managing andropause. In this article, we clarify the common myths around andropause to better inform primary care physicians and their patients. We discuss the Canadian guidelines on diagnosis and management of testosterone deficiency. Finally, we provide insight into the safety of testosterone-replacement therapy. By implementing structured monitoring and shared decision making, primary care physicians can ensure safe, effective, and evidence-based care for aging Canadians.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.